| Zeit | Aktuelle Nachrichten | ||
|---|---|---|---|
| 24.08. | Ashland Launches Permexa Sodium Caprate High-Performance Intestinal Permeation Enhancer | ||
| 24.08. | Barentz Appoints Matt Mitchell as Global VP, Pharmaceuticals | ||
| 24.08. | AN2 Therapeutics Names Dr. Cameron Trenor as Chief Medical Officer | ||
| 24.08. | Werewolf, Ambros to Merge in All-Stock Deal | ||
| 21.08. | Alvotech, Lotus Ink Biosimilar Licensing and Commercialization Pact in US, Asia | ||
| 21.08. | MedPharm Expands End-to-End Proteomic Analysis Capabilities with Olink Certification | ||
| 21.08. | Genentech to Invest $750M in Oregon Manufacturing Site | ||
| 21.08. | Halo Pharma to Activate Sterile Injectable Line in NJ | ||
| 20.08. | Sino Biopharmaceutical Launches SBP Group, Its New Global Brand | ||
| 20.08. | Charles River, Medigen to Validate Virus Seed Bank for Next-Gen Enterovirus Vaccine | ||
| 20.08. | Bristol Myers Squibb, Chai Partner on AI Antibody Discovery | ||
| 20.08. | IAG Cargo Adds Kuala Lumpur to Pharma Network | ||
| 19.08. | Crescendo Health Taps David Strutton as Chief Scientific Officer | ||
| 19.08. | Genentech Completes Structural Framework in Construction of NC Manufacturing Facility | ||
| 19.08. | Cytovance Biologics Expands Analytical Services Portfolio with Standalone Capabilities | ||
| 19.08. | Qosina Launches Regulatory Services | ||
| 19.08. | Syntegon Launches Sepion 75 Tablet Coater | ||
| 19.08. | Andelyn Biosciences Partners With Queen's University on GM2 Gene Therapy | ||
| 19.08. | BioSkryb Genomics Names Dr. William Evans as CEO | ||
| 19.08. | SK pharmteco Completes Facility Expansions in Swords, Ireland | ||
| 19.08. | Bespak Earns Gold EcoVadis Sustainability Rating | ||
| 19.08. | Piramal Pharma Acquires Majority Stake in Yapan Bio | ||
| 17.08. | Juvena Therapeutics Names Julie Anne Smith CEO | ||
| 17.08. | Emergent BioSolutions Restructures | ||
| 17.08. | Henlius, Sandoz Expand Oncology Biosimilars Partnership with mAbs, ADCs |